The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases
Background. Over the last 25 years, clinical practice guidelines have emerged as a means to standardize and improve care. As pharmaceutical innovations develop, guidelines are updated to incorporate new interventions. However, the extent to which pharmacotherapies are represented as treatment option...
Saved in:
Main Authors: | Meaghan Roach, Natalie Land, Jennifer Hernandez, Reina Rau, Jacquelyn W. Chou, Stacey S. Hickson, Danielle F. Rollmann, J. Ross Maclean |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | International Journal of Clinical Practice |
Online Access: | http://dx.doi.org/10.1155/2024/5877687 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET
by: E. A. Bykova
Published: (2020-09-01) -
Clinical Practice Guidelines for Severe Chronic Obstructive Pulmonary Disease.
by: Niurka Mercedes Galende Hernández, et al.
Published: (2009-03-01) -
Pharmaceutical Innovations: Superior Position of the USA and Weaknesses of German Research
by: Andreas Eckert, et al.
Published: (2021-08-01) -
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
by: Sabine Vogler, et al.
Published: (2024-04-01) -
Guidelines for Implementing Innovations in Hospital Organizations
by: Josiano Cesar de Sousa, et al.
Published: (2022-01-01)